Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203
NCT02115568 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 165
Last updated 2014-04-16
Summary
This is an exploratory registry that will include subjects who have been randomized to receive JVS-100 treatment (at one of multiple doses) or placebo by one of a number of delivery systems (e.g. endomyocardial injection, retrograde infusion) in a previous Juventas clinical trial.
Conditions
- Ischemic Heart Failure
Sponsors & Collaborators
-
Juventas Therapeutics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
Countries
- United States
Study Locations
More Related Trials
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
NCT03764722 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
NCT00259038 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
NCT02441218 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
NCT05659264 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
NCT05350969 ·Status: COMPLETED ·Phase: PHASE2
-
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada
NCT02957409 ·Status: COMPLETED
-
Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT04210375 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents
NCT02201342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
NCT05949801 ·Status: COMPLETED ·Phase: PHASE3
-
St. Vincent's Screening To Prevent Heart Failure Study
NCT00921960 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Cenderitide in Stable Chronic Heart Failure
NCT02359227 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event
NCT02661217 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
NCT01922089 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
NCT00160134 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure
NCT03387163 ·Status: COMPLETED
-
If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure
NCT00757055 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
NCT07221513 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children
NCT01301313 ·Status: TERMINATED ·Phase: PHASE2
-
Levosimendan In Ambulatory Heart Failure Patients
NCT04705337 ·Status: TERMINATED ·Phase: PHASE4
-
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
NCT06625307 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
NCT03456856 ·Status: COMPLETED ·Phase: PHASE4
-
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation
NCT05991284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4